Canopy Growth Stock News

The Canada-based pot producer announced better-than-expected fiscal third-quarter results

Canopy Growth reported a net loss of 115 million Canadian dollars ($90 million) in its quarter ended Dec. 31, 2021, on lower cannabis sales in its important Canada market. Canopy Growth loses CA$115 million in quarter on lower cannabis sales is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Cannabis stocks are up today as some companies report earnings. Sundial Growers has its own cause to celebrate as its story continues.

Canopy Growth reported better-than-expected overall revenue in its most recent quarter.

Canopy Growth Corp. (NASDAQ: CGC ) shares are trading higher Wednesday after the company announced its fiscal third-quarter financial results . Canopy Growth reported quarterly revenue of CAD$155 million ($122.14 million), which was down from CAD$169.9 million year-over-year. The company reported a quarterly earnings loss of CAD$0.28 per share, which was up from a loss of CAD$2.43 per share year-over-year. Canopy Growth was up 14.82% at $8.83 at time of publication. See Also: Canopy Growth Shares Are Trading Higher Today, Analysts Tell Us Why Canopy Growth Daily Chart Analysis Shares have spent months trading in what traders call a downward channel and are now nearing Full story available on Benzinga.com

Canopy Growth (CGC) stock is heating up on Wednesday following strong results in the marijuana company''s fiscal third quarter of 2022.

Canopy Growth Corp (CGC) CEO David Klein on Q3 2022 Results - Earnings Call Transcript

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC ) reported its financial results Wednesday for the third quarter fiscal 2022 ended December 31, 2021, revealing a decline of 8% sequentially in net revenue to CA$141 million (US$111.12 million). Cantor Fitzgeralds analyst Pablo Zuanic said sales were in line with his estimate. However, global cannabis revenue came in at CA$83 million, well below the analysts estimate of $CA91 million, while consumer products sales reached CA$58 million, beating estimates of CA$50 million. Lisa K. Lewandowski, BofA Securities research analyst, said in her note that net sales were driven by stronger growth from other consumer products including Storz & Bickel vaporizers and BioSteel beverages partly Full story available on Benzinga.com

Canopy growth''s sports hydration business BioSteel and Storz & Bickel, its medical vaporizer arm, generated record quarterly revenue.

Canopy Growth Corp (NASDAQ: CGC ) is trading higher Wednesday morning after the company announced its fiscal third-quarter financial results. Canopy Growth reported quarterly revenue of CAD$155 million ($122.14 million), which was down from CAD$169.9 million year-over-year. The company reported a quarterly earnings loss of CAD$0.28 per share, which was up from a loss of … Full story available on Benzinga.com

Canopy Growth (CGC) has sparked an uptick in the shares of other Canadian licensed producers in the pre-market on Wednesday after posting better than expected financials for Q3

Canopy Growth Corp. shares rallied on stronger-than-expected third-quarter revenue, as the company aired plans to focus on premium cannabis brands in Canada and growth in a line of drinks and CBD prod

Canada-based weed stock Canopy Growth Corp (NASDAQ:CGC) is on fire today, up 16.3% to trade at $8.94, following the company's narrower-than-expected fiscal third-quarter losses per share and revenue b

Shares of Canopy Growth Corporation (NASDAQ: CGC) are up more than 16% after the release of FQ3 earnings but we aren't buying into the rally, at least not yet. As much as we'd like to see this company